Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 ,inter alia, to consider and approve and take on record ....
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Entero Healthcare Solutions has informed BSE and NSE that its Board of Directors will meet on Friday, August 8, 2025. The key agenda is to consider, approve, and take on record the unaudited standalone and consolidated financial results (along with limited review report) for the quarter ended June 30, 2025, i.e., Q1 FY26. The filing is made under SEBI LODR Regulation 29. The company has also reminded that the trading window for designated persons and their immediate relatives remains closed from July 1, 2025, until 48 hours after the results are uploaded to the stock exchanges.
This is a routine advance intimation and does not contain any financial numbers. Shareholders should watch for the actual Q1 FY26 results on or after August 8, 2025, which will provide the first earnings update for the current financial year and could move the stock depending on the numbers reported.